
Opinion|Videos|August 27, 2025
Unmet Needs for the Management of Alopecia Areata
Key Takeaways
- Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles.
- Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells.
Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments fail, though it can create a cost burden, and how beyond updated guidelines, there are unmet needs such as improved long-term treatments and better psychological support for patients.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Mostaghimi: What is your approach to switching therapies in patients with AA?
- Discuss how switching therapies can be a cost burden for patients.
- Friedland: Beyond updated guidelines for AA, what are some other unmet needs for the management of this disease?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
NYC Legionnaires Disease Cluster Slows as Cooling Tower Remediation Continues
2
Female Newborns More Likely to Miss Vitamin K Prophylaxis, Hepatitis B Birth Dose
3
FDA Approved At-Home SC Lecanemab Initiation Dose for Early Alzheimer Disease
4
Medicaid Fraud Crackdown Intensifies, But Is It Solving the Right Problem?
5



